Chloramphenicol acetyltransferase [acetyl-CoA:chloramphenicol 03-acetyltransferase; EC 2.3.1.28] is the enzyme responsible for high-level bacterial resistance to the antibiotic chloramphenicol. It catalyzes the transfer of an acetyl group from acetyl CoA to the primary hydroxyl of chloramphenicol. The x-ray crystallographic structure of the type m variant enzyme from Escherichia cofl has been determined and refined at 1.75-resolution. The enzyme is a trimer of identical subunits with a distinctive protein fold. Structure of the trimer is stabilized by a 13-pleated sheet that extends from one subunit to the next. The active site is located at the subunit interface, and the binding sites for both chloramphenicol and CoA have been characterized. Substrate binding is unusual in that the two substrates approach the active site via clefts on opposite molecular "sides." A histidine residue previously implicated in catalysis is appropriately positioned to act as a general base catalyst in the reaction.
Resistance to antibiotics in pathogenic bacteria is an increasingly common phenomenon, which has serious implications for clinical medicine. The resistance is frequently achieved by enzymatically catalyzed covalent modification of the drug. For chloramphenicol, inactivation is achieved by 0-acetylation. Because the modified drug no longer binds to a bacterial ribosome, which is its normal site of action, the drug loses its effect as an antibiotic (1) . The enzyme responsible for this acetylation is chloramphenicol acetyltransferase (CAT) (acetyl-CoA:chloramphenicol acetyltransferase; EC 2.3.1.28), which catalyzes transfer of an acetyl group from acetyl CoA to the primary hydroxyl (C-3) of chloramphenicol (Cm) (2) (3) (4) . The CAT gene is commonly, but not exclusively, plasmidborne in natural isolates and has been found to be a component of plasmids conferring multiple drug resistance, especially in Gram-negative bacteria and the Enterobacteriaceae, in particular (5) . Amino acid sequences of several variants of CAT from both Gram-positive and Gram-negative bacteria have been determined (6) (7) (8) (9) (10) (11) . All known variants have similar subunit molecular weights (Mr 25,000) and are highly homologous, indicating similar tertiary structure. This conclusion had been inferred from earlier studies of hybrids formed in vivo and in vitro between naturally occurring variants (12, 13) . Although the hybridization results were originally interpreted in terms of a tetrameric structure for CAT, crystallographic work and more recent hydrodynamic results (14) clearly show that CAT is a trimer, a relatively unusual oligomeric symmetry for a soluble enzyme. Of known variants of CAT, those currently best characterized are the type I protein, typified by the CAT encoded by transposon Tn9 and in wide use as a tool for studying gene expression in eukaryotic systems (15) , and the type III variant, which has been studied by kinetic and chemical methods (16, 17) and which is currently the only variant to yield crystals suitable for x-ray diffraction studies (18) .
We report here the three-dimensional structures of two binary complexes of CAT, one with the substrate chloramphenicol bound and the second with bound CoA (a product of the forward reaction and substrate for the reverse reaction). Structure Determination Crystals of the binary complex of the enzyme with bound chloramphenicol were obtained by microdialysis ofprotein (5 mg/ml) in 10 mM Mes, pH 6.3, against 2% (vol/vol) 2-methyl-2,4-pentandiol/10 mM Mes, pH 6.3/1 mM chloramphenicol/0.5 mM hexaminecobalt(III) chloride (18 (20) , which incorporates the chain-tracing algorithm of Greer (21) . A molecular model was built from the known-amino acid sequence with the use of the "fragment fitting" feature (22) Crystals of the enzyme with bound CoA were obtained by microdialysis of protein (5 mg/ml) against 18% 2-methyl-2,4-pentandiol/10 mM Mes, pH 6.3/0.7 mM CoA/5 mM 13-mercaptoethanol/0.5 mM hexaminecobalt(III) chloride.
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These crystals are isomorphous with those of the enzyme with bound chloramphenicol. X-ray data were collected to 2.4-A resolution (Table 1) . A difference electron-density map between the two binary complexes using model phases clearly revealed the position of bound CoA. The structure of the enzyme-CoA complex was refined at 2.4-A resolution, using the refined structure of the enzyme-chloramphenicol complex as a starting model. The final refined structure has a crystallographic R factor of 20.4% for all data between 10 A and 2.4 A and good stereochemistry ( Table 2) . General Description of the Structure The dominant feature ofthe structure ofthe monomer, shown schematically in Fig. 1 , is a six-stranded predominantly (Figs. 2 and 3) . The residues lining the pocket are predominantly hydrophobic, and there are only two direct hydrogen bonds between the substrate and the enzyme, with an additional hydrogen bond via a bridging water molecule. Only five of these residues are strictly conserved among all known CAT sequences, but the observed substitutions are always conservative. The conformation of chloramphenicol is very similar to that seen in the single-crystal structure (27) (28) . The major difference is that the primary (C-3) hydroxyl of enzyme-bound chloramphenicol (the acetyl acceptor in the forward reaction) adopts an alternative staggered conformation to that seen in the crystal structure of the antibiotic. As a consequence, the primary hydroxyl is correctly placed to form a hydrogen bond with the ring nitrogen (N-3) of the active site histidine (His-195) (Fig. 3) . The nitro group and one of the two chlorines point out of the pocket and are solvent-accessible, consistent with results of kinetic studies of CAT that demonstrated acetyl acceptor activity with chloramphenicol analogues having substitutions for the pnitro and N-dichloroacetyl moieties (5 completely blocked from the top of the enzyme as viewed in Fig. 2 . This suggests that the second substrate (acetyl CoA) must approach the active site from a different direction because no kinetic evidence favors the view that ordered binding of the substrates is obligatory (16) . In the refined structure of the CAT-chloramphenicol complex a remarkable tunnel leads from the active-site histidine out to the lower surface of the enzyme (as viewed in Fig. 2 Location of bound CoA is shown in Fig. 2 , and a more detailed picture of the residues involved in binding is given in Fig. 4 . Hydrophobic interactions clearly play an important role in CoA binding. The pantetheine arm is almost fully extended and runs between the carboxyl ends of strands 13B and P1D of the p-pleated sheet. Both main-chain and sidechain atoms from residues on these two strands together with the side chains of Tyr-56, Phe-96, and Phe-103 contribute to the formation of the tunnel-like binding pocket. In contrast to the pantetheine arm, the adenosine 5'-diphosphate component adopts a folded conformation that brings the adenine ring into van der Waals contact with the dimethyl group ofthe pantetheine arm. The ribose conformation is C2-endo, and the glycosidic torsion angle is anti. The adenine ring binds in a hydrophobic pocket formed by the side chains of Phe-55, Pro-151, and Tyr-178 and forms hydrogen bonds with the (Fig. 4) . Surprisingly, there are no basic side chains interacting directly with any of the three phosphate groups, nor are any of the phosphate groups in a position that would lead to a favorable interaction with the dipole moment of an a-helix, as is commonly seen in the structures of dinucleotide-binding proteins (29) .
In some respects the mode of binding of CoA is rather similar to that seen in citrate synthase (30) : the pantetheine arm is completely shielded from bulk solvent, while the phosphate groups are located at the enzyme surface. However, the conformation of CoA is quite different in the two structures. When bound to citrate synthase, the molecule adopts a much more compact folded conformation, characterized by two internal hydrogen bonds (one via a bridging water molecule). Details of the interactions are also rather different. The adenine ring forms hydrogen bonds to mainchain atoms in both structures, but in CAT there is no obvious counterpart to the "adenine recognition loop" described for citrate synthase. In addition, the phosphate groups are coordinated by three arginine residues in citrate synthase, whereas no similar feature exists in CAT. In view of the conformational flexibility of CoA, lack of similarity between the binding sites in these two enzymes is, perhaps, not surprising.
Interestingly, in the absence of bound chloramphenicol, the acetyl-CoA tunnel and the chloramphenicol-binding cleft (17) and site-directed mutagenesis (31) have indicated that His-195 plays an essential role in catalysis and also implicate the carboxyl group of Asp-199. Steady-state kinetic studies (16) suggest a ternary complex (sequential) rather than a ping-pong mechanism, arguing for a general base role for His-195, with deprotonation of the C-3 hydroxyl of chloramphenicol and nucleophilic attack on the carbonyl of the thio ester of acetyl CoA (Fig. 5) . The present structure reveals a network of hydrogen bonds in the active site (Fig. 6 ). Asp-199 (conserved in known sequences) is involved in a salt-bridge to the side chain of Arg-18 (also conserved), which, in turn, is within hydrogenbonding distance f the main-chain carbonyl oxygens of residues 195 and 196. The side chain ofthe active-site adopts an unusual conformation (X1 = -146, X2 = -29), which allows formation of a hydrogen bond between the imidazole nitrogen N-1 and the carbonyl oxygen of the same residue. (A search of the Brookhaven data base revealed no other example of this type of interaction.) The imidazole ring is also in van der Waals contact with the benzene ring of Tyr-25 (Fig. 3) , and this interaction may help stabilize the side-chain orientation. The unusual conformation of His-195 would allow the imidazole N-3 nitrogen to abstract a proton from the primary hydroxyl of chloramphenicol, consistent with the mechanism outlined above (Fig. 5) .
When the CoA coordinates from the enzyme-CoA complex are transposed into the refined enzyme-chloramphenicol model, the thiol group is positioned at distances of 3.3 A and 2.8 A from the N-3 nitrogen of His-195 and the primary hydroxyl of chloramphenicol, respectively. Thus, no major structural rearrangement is needed to bring the components into proximity for catalysis to proceed, although further work is necessary to grasp the details of this mechanism. Sitedirected mutagenesis of residues in the active site (31) should help clarify the role of individual amino acids in catalysis.
